Clinical Trial Update: Trial for Patients With Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma [Phase 2]

View source ↗

Summary

This update reports results from a Phase 2 trial for newly diagnosed primary central nervous system lymphoma conducted by IELSG; the trial is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Central Nervous System Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2026-03-19